Concord Medical Services
3 hedge funds and large institutions have $16.8K invested in Concord Medical Services in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less capital invested
Capital invested by funds: $23.7K → $16.8K (-$6.91K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.57K |
CCM Hedge Fund Activity: Q4 2024 in Review
3 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q4 2024, worth a combined $16.8K — down 29% from $23.7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CCM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $1.57K.
- 3 institutional investors held Concord Medical Services (CCM) as of Q4 2024, up from 2 in Q3 2024.
- Funds reported $16.8K of Concord Medical Services stock for Q4 2024, down 29% quarter-over-quarter.
- 1 fund opened new Concord Medical Services positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest Concord Medical Services seller in Q4 2024 was UBS Group, an estimated $1.57K sold.
Based on aggregated 13F filings for Q4 2024.